Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2014; 20(10): 2653-2663
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2653
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2653
Figure 7 Effect of exenatide on glucose tolerance.
Intraperitoneal glucose tolerance tests (IPGTTs) were performed in the high-fat diet (HFD)-Ex(+) and HFD-Ex(-) groups at week 12 of feeding. Fasting plasma glucose levels were slightly lower in the HFD-Ex(+) group than in the HFD-Ex(-) group, but no significant differences were observed at the other times during the IPGTTs.
- Citation: Tanaka K, Masaki Y, Tanaka M, Miyazaki M, Enjoji M, Nakamuta M, Kato M, Nomura M, Inoguchi T, Kotoh K, Takayanagi R. Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats. World J Gastroenterol 2014; 20(10): 2653-2663
- URL: https://www.wjgnet.com/1007-9327/full/v20/i10/2653.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i10.2653